Unitree priced its Shanghai IPO at $9.04 billion — the first public humanoid robot maker, and the only one turning a profit while rivals like Figure AI sit at $39B with no revenue.
CuspAI raised a $450M Series B at a $2.6B valuation to build MIRA, an AI that searches for materials that don't exist yet — backed by Kleiner Perkins, NVIDIA, Meta and Bezos.
Apple posted a record $109.4B June quarter, up 16%, with iPhone up 22% — and the stock still dropped as Services and China came up short.
Etched raised $300M at a $10.3B valuation for Sohu, a chip that runs transformers and nothing else — a pure bet that the architecture is done changing.
Enigma exited stealth with a $71 million seed - one of robotics' largest first checks - on a contrarian bet: the bottleneck isn't smarter robots, it's making them usable.
DeepSeek went out for about $7 billion and investors came back with at least $12 billion, in a Tencent- and CATL-led round ahead of a planned 2027 IPO.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
The FDA just approved FAYUVI, the first-ever treatment for Sanfilippo syndrome type A: a one-time gene therapy from Ultragenyx priced at $3.95 million per patient.
Adicet's off-the-shelf CAR-T put 54% of a small lupus trial into remission on a single dose. Then the stock dropped 22%.
Precision Neuroscience closed an oversubscribed $250M Series D at a ~$1B valuation, betting its surface brain implant beats drilling into tissue.
